Mission Statement, Vision, & Core Values (2026) of Jiuzhitang Co., Ltd.

From its founding as Laojiuzhitang Pharmacy Store in 1650 to its modern incarnation listed on the Shenzhen Stock Exchange as 000989.SZ, Jiuzhitang Co., Ltd. blends a centuries-old TCM heritage with contemporary pharmaceutical research, operating an integrated network of production, sales, research and health management across more than 30 subsidiaries and upwards of 500 chain stores; guided by the mission "Centuries of Jiuzhitang Serves big health." the company pursues whole-life-cycle health management-prevention, treatment and rehabilitation-while its vision, "Provide valuable health products and services for mankind, and become the public's preferred health partner," and core value, "Focus on mankind's needs for better health," drive a customer-centered strategy that has earned recognition as a national innovative pilot enterprise and a key construction unit under the National Administration of TCM, positioning Jiuzhitang at the intersection of traditional wisdom and modern health solutions

Jiuzhitang Co., Ltd. (000989.SZ) - Intro

• Founded: 1650 (Laojiuzhitang Pharmacy Store)
• Stock code: 000989.SZ (Shenzhen Stock Exchange)
• Business scope: TCM manufacturing, retail chain, R&D, health management
• Organizational scale: operates over 30 subsidiaries and more than 500 chain stores
• National recognition: national innovative pilot enterprise; key TCM engineering construction unit under the National Administration of TCM

• Preserve and innovate traditional Chinese medicine to improve population health across the whole life cycle.
• Deliver integrated TCM solutions combining heritage formulas, modern production standards, and digital health services.

• Become a globally recognized TCM health ecosystem provider that integrates clinical heritage with modern science and digital health management.
• Scale whole-life-cycle health services to meet aging-population needs and chronic-disease management in China and abroad.

• Heritage & Innovation - respect traditional knowledge while driving scientific validation and technological modernization.
• Quality & Safety - adhere to stringent production and quality-control standards across manufacturing and retail.
• Patient-Centric Care - focus on preventative, chronic and restorative health solutions over the full life course.
• Integrity & Responsibility - operate with regulatory compliance, social responsibility, and commitment to public health.
• Collaboration & Talent - invest in multidisciplinary R&D, clinical partnerships, and talent cultivation to sustain long-term growth.

• R&D and product modernization: expand clinical research and standardization of TCM formulas to increase evidence-based adoption.
• Retail and service ecosystem: grow and optimize >500 chain stores and digital health touchpoints for integrated health management.
• Manufacturing scale and quality systems: maintain GMP-compliant facilities and strengthen supply-chain traceability.
• Market expansion: leverage national recognition to deepen presence in higher-tier Chinese markets and explore cross-border opportunities.

Jiuzhitang Co., Ltd. (000989.SZ) - Overview

• Heritage: a multi-century lineage that positions the company as a custodian of TCM knowledge and manufacturing practice.
• Scope of 'big health': integration of TCM products, health supplements, clinical TCM services, and chronic disease management.
• Continuity: the mission phrase has been a steady guiding statement, reflecting strategic consistency across product development, brand stewardship, and public-health initiatives.

• R&D orientation: prioritizes evidence-based modernization of classical formulations and clinical research linking TCM with contemporary treatment pathways.
• Portfolio breadth: balances traditional decoctions and patented TCM formulas with health-management services and preventive-care products.
• Market positioning: aims to serve mass-market health needs while maintaining premium brand recognition for heritage products.

• Product pipeline focused on chronic-disease adjunct therapies and preventive-care supplements, with target CAGR for this segment of 12-15% over the next 3-5 years.
• Investment in clinical trials and standardization: expanding evidence base to support integration of TCM into mainstream care pathways.
• Brand and heritage monetization: leveraging centuries-long provenance to maintain premium SKU margins and international licensing opportunities.

• Board oversight emphasizes long-term health outcomes and patient safety alongside shareholder returns.
• Quality systems rooted in TCM formulation fidelity plus modern GMP compliance.
• Community and public-health programs aim to increase access to preventive care and health education in urban and rural areas.

Jiuzhitang Co., Ltd. (000989.SZ) - Mission Statement

• Customer-first focus: build trust through quality assurance, safety testing, and transparent labeling.
• Evidence-driven innovation: combine TCM formulations with modern R&D and clinical validation.
• Accessibility: expand retail, online and medical channels so products and services reach diverse populations.
• Sustainable growth: balance revenue objectives with long-term investments in people, quality systems, and ecological sourcing.

• High-quality offerings: continual improvement of product and service quality through GMP, pharmacovigilance, and post-market surveillance.
• Trusted relationships: positioning Jiuzhitang as the default health partner by improving retention, satisfaction, and education.
• Industry leadership: adapt to shifting consumer needs and regulatory environments to lead the TCM and health-product ecosystem.

• Integrity - compliance, transparent reporting, and ethical sourcing.
• Quality - stringent manufacturing and QA standards across herbal extracts, granules, OTCs and functional foods.
• Innovation - continuous R&D investment to modernize formulations and delivery systems.
• People-centered care - focus on patient outcomes, professional training, and customer service excellence.

• Quality systems upgrade - investment in manufacturing facilities and third-party certifications to reduce batch variance and improve first-pass release rates.
• Digital channels - expanding e-commerce, telehealth consultations, and loyalty programs to increase customer lifetime value.
• Clinical validation - running real-world studies and collaborating with hospitals to strengthen evidence base for core products.
• Supply chain resilience - traceability programs and sustainable sourcing to secure key herbal inputs and meet regulatory traceability demands.

• Customer satisfaction (NPS / CSAT) and repeat-purchase rate targets.
• Market share in core TCM categories and OTC functional-food segments.
• R&D pipeline milestones (IND/clinical study starts, registrations, IP filings).
• Operational KPIs: on-time delivery, batch-release yield, adverse-event reporting timelines.

Jiuzhitang Co., Ltd. (000989.SZ) - Vision Statement

• Customer-centric health innovation: prioritize therapies and services that respond directly to evolving public health needs.
• Integration of tradition and science: combine TCM knowledge with modern R&D, clinical validation, and manufacturing standards.
• Accessible preventive care: expand distribution, community health programs, and affordable product lines for broad public benefit.
• Sustainable growth: pursue profitable expansion while safeguarding product quality, patient safety, and environmental responsibilities.

• Dedication to addressing human health needs through preventive and therapeutic TCM products and services.
• Continuous monitoring of population health trends to adapt product pipelines and public-health initiatives.
• Prioritization of public health outcomes in strategic decisions-marketing, R&D investments, and partnerships.
• Balanced portfolio strategy: traditional formulas, proprietary preparations, and targeted modern drug development.

• R&D pipeline prioritization: prioritize indications with large unmet needs (chronic disease management, preventive care, immune support).
• Quality assurance: investment in GMP upgrades and third-party clinical validation to ensure product safety and efficacy.
• Distribution expansion: strengthen community pharmacies, hospital TCM departments, and e-commerce channels to increase access.
• Public health programs: scale education campaigns and subsidized product initiatives for elderly and rural populations.

• Revenue mix shift: increasing share from modernized TCM preparations and high-margin proprietary products.
• Margin resilience: gross margin maintained above 50% through product mix optimization and cost controls.
• Investments in science: steady R&D spend supporting clinical studies and new formulation approvals.
• Community impact: expanded outreach programs and partnerships with regional health centers to deliver preventive care.